General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis

2014 ◽  
Vol 31 (2) ◽  
pp. 353-365 ◽  
Author(s):  
Sung Ryul Shim ◽  
Jae Heon Kim ◽  
Hoon Choi ◽  
Won Jin Lee ◽  
Hae Joon Kim ◽  
...  
Keyword(s):  
Lower Urinary Tract ◽  
Low Dose ◽  
Meta Analysis ◽  
Prostatic Hyperplasia ◽  
General Effect ◽  
Line Treatment ◽  
First Line ◽  
Urinary Tract Symptoms ◽  
First Line Treatment ◽  
Lower Urinary

Non-uroselective and uroselective α1-adrenolitics in everyday urological practice – the duel

2020 ◽  
Vol 13 (3) ◽  
pp. 275-278
Author(s):  
Kajetan Juszczak ◽  
Tomasz Drewa
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Lower Urinary Tract ◽  
Low Frequency ◽  
Prostatic Hyperplasia ◽  
First Line ◽  
Onset Of Action ◽  
Specific Patient ◽  
Urinary Tract Symptoms ◽  
First Line Treatment ◽  
Lower Urinary

α1-adrenolitics are often considered the first-line treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) due to their quick onset of action, good efficacy and low frequency and severity of side effects. α1-adrenolitics are divided into non-uroselective and uroselective. The study compared two drugs, such as doxazosin and tamsulosin. The presented duel and its result may help in choosing the best treatment option for a specific patient with benign prostatic hyperplasia.

Sign in / Sign up

Export Citation Format

Share Document